Cantitate/Preț
Produs
Total produse
Vezi coșul
Immunosuppression Under Trial de Conference On Transplantation and Clinic

Immunosuppression Under Trial: Transplantation and Clinical Immunology, cartea 31

Autor Conference On Transplantation and Clinic, P. Cochat, J. Traeger
en Limba Engleză Hardback – 30 apr 1999
Immunosuppression in solid organ transplantation is currently experiencing a worldwide revival since new drugs are now available and others are under development. In order to contribute to the design of future strategies, a critical approach of surrogate endpoints is given and long-term side effects are analysed, together with the impact of non-compliance, quality-of-life and economical parameters. In this book, international specialists have set up the scientific rationale and provided new bases for further immunosuppressive strategies.
Citește tot Restrânge

Din seria Transplantation and Clinical Immunology

  • 5% The Clinical Applications of Spet
    Preț: 69516 lei
  • 5% Rejection and Tolerance: Proceedings of the 25th Conference on Transplantation and Clinical Immunology, 24–26 May 1993
    Preț: 36771 lei
  • 5% Organ Shortage: The Solutions: Proceedings of the 26th Conference on Transplantation and Clinical Immunology, 13–15 June 1994
    Preț: 36069 lei
  • 5% Cancer in Transplantation: Prevention and Treatment: Proceedings of the 27th Conference on Transplantation and Clinical Immunology, 22–24 May 1995
    Preț: 69287 lei
  • 5% Late Graft Loss: Proceedings of the 28th Conference on Transplantation and Clinical Immunology, 3–5 June, 1996
    Preț: 136114 lei
  • 5% Retransplantation: Proceedings of the 29th Conference on Transplantation and Clinical Immunology, 9–11 June, 1997
    Preț: 106387 lei
  • 5% Organ Allocation: Organized by Fondation Marcel Ma(c)Rieux and Universita(c) Claude Bernard - Lyon 1
    Preț: 63376 lei
  • 5% Organ Allocation: Proceedings of the 30th Conference on Transplantation and Clinical Immunology, 2–4 June, 1998
    Preț: 35646 lei
  • 5% Immunosuppression under Trial: Proceedings of the 31st Conference on Transplantation and Clinical Immunology, 3–4 June, 1999
    Preț: 34944 lei
  • 5% Transplantation and Changing Management of Organ Failure: Proceedings of the 32nd International Conference on Transplantation and Changing Management of Organ Failure, 25–26 May, 2000
    Preț: 35294 lei

Preț: 62322 lei

Preț vechi: 65602 lei
-5% Nou

Puncte Express: 935
Preț estimativ în valută:
11928€ • 12583$ • 9940£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792358046
ISBN-10: 079235804X
Pagini: 178
Dimensiuni: 156 x 234 x 14 mm
Greutate: 0.45 kg
Editura: Springer
Seria Transplantation and Clinical Immunology

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

Preface. Part 1: Setting the stages in clinical trials. 1. Current results as reference for future improvements in immunosuppression; G. Opelz, et al. 2. Rationale of clinical trials from the physician; C. Legendre. 3. Minimal standards for reporting clinical trial results in transplantation; B.L. Kasiske, H. Chakkera. 4. Methodological approach of clinical trials for renal transplantation; P. Landais, J.P. Jais. Part 2: Is acute rejection an appropriate surrogate marker? 5. Surrogate end-points for clinical trials in renal transplantation; B.L. Kasiske. 6. Is acute rejection an appropriate surrogate marker for clinical trials in liver transplantation? O. Farges. 7. The success of clinical immunosuppressive trials in heart transplantation: the early detection of acute rejection; M. Antoine. Part 3: Towards long-term end-points. 8. Factors influencing long-term allograft survival; C. Van Buren. Part 4: Can we minimize the long-term side-effects? 9. Patients' appraisal of side-effects in quality of life assessments of immunosuppressive regimens; P. Moons, et al. 10. Cardiovascular complications after renal transplantation; V. Schwenger, et al. 11. Strategies to minimize nephrotoxicity associated with calcineurin inhibitors; J. Alsina. 12. Diabetogenic effect of immunosuppressive drugs; X. Martin. 13. Can we minimize long-term side effects of immunosuppressive drugs on lipid metabolism? Z.A. Massy. 14. Can we minimize the long-term side-effects of immunosuppressive drugs in pediatric patients? B. Tönshoff, et al. Part 5: Strategies. 15. Induction therapy; D. Abramowicz, K.M. Wissing. 16. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens; J. Dantal, et al. 17. Immunosuppression in composite tissue transplantation; J.-M. Dubernard, et al. 18. The search for immunosuppressive synergy; C. Van Buren. 19. Economic analysis of immunosuppression in transplantation: a review of recent studies in liver and kidney transplantation; J. Hutton. Part 6: Clinical trials for at-risk situations. 20. Questions raised by the exclusion of `at risk' conditions from current trials in organ transplantation; J.P. Revillard, et al. List of contributors.